2023 Program

Stephen Trzeciak, MD, MPH is a physician scientist, Chief of Medicine at Cooper University Health Care, and Professor and Chair of Medicine at Cooper Medical School of Rowan University in Camden, New Jersey. Dr. Trzeciak is a practicing intensivist (specialist in intensive care medicine), and a clinical researcher with more than 120 publications in the scientific literature. Dr. Trzeciak’s publications have been featured in prominent medical journals, such as: JAMA, Circulation, and The New England Journal of Medicine. His scientific program has been supported by research grants from the National Institutes of Health (NIH), with Dr. Trzeciak serving as Principal Investigator.

Dr. Trzeciak is the co-author of Compassionomics: The Revolutionary Scientific Evidence that Caring Makes a Difference (2019), and Wonder Drug: 7 Scientifically Proven Ways That Serving Others Is the Best Medicine for Yourself (2022). His work has been featured in numerous media outlets including CNN, NPR, USA TODAY, The Washington Post, Harvard Business Review, and Freakonomics. For this work, he was awarded the Influencers of Healthcare Award by The Philadelphia Inquirer. Broadly, Dr. Trzeciak’s mission is to raise compassion and kindness globally, through science.

Dr. Trzeciak is a graduate of the University of Notre Dame. He earned his medical degree at the University of Wisconsin-Madison, and his Master’s of Public Health at the University of Illinois at Chicago. He completed his residency training at the University of Illinois at Chicago, and his fellowship in critical care medicine at Rush University Medical Center. He is board certified in internal medicine, critical care medicine, and neurocritical care.

Brad Millson is General Manager of the Oncology Practice within the Real World Solutions consulting group at IQVIA. He leads the strategic operations and development of our growing oncology business. Previously, Brad was Principal, Real World Solutions at IQVIA, responsible for market access strategy and real-world evidence-based solutions for the pharmaceutical industry and its stakeholders. He joined the company in 2013, bringing his global expertise in pharmaceutical brand management, strong medical science training, and strategic problem solving across government and private sectors to the organization. Brad is recognized as a thought leader for his expertise in health outcomes, market access and policy strategy.

ROLE: Jacob leads COGNITIVE by ZS where ZS is a leader in helping clients commercialize behavioral and cognitive science to improve the impact of their sales and marketing.

EXPERTISE: Jacob has over 18 years of experience in brand and marketing strategy. For the past several years he has been one of the leading voices on how brands and companies can bring understanding of cognitive biases and unconscious decision making into the way they think about and communicate with customers.

PRIOR EXPERIENCE: Jacob’s background is as a strategic leader on the agency side where he has led brand strategy for healthcare products across a wide range of categories and audiences, including three of the Top 5 bestselling pharmaceutical products worldwide. His articles on the potential to shape behavior with behavioral insights in Fast Company, Ad Age, and Forbes.

EDUCATION: Jacob holds a B.A. in Communications from the University of North Carolina at Chapel Hill.

Don Watts has over 2 decades of experience in the Life Sciences industry with commercial leadership and general management roles in both Pharmaceutical and Medical Device businesses with companies like Organon Biosciences, Bausch and Lomb, Medtronic, and Fresenius Medical Care.  During this time he has gained national and global commercial experience in many areas of healthcare including primary care, numerous specialties, hospital/surgical businesses, specialty pharma, and capital equipment.

Don has a BSc from Western University and an MBA from the Richard Ivey School of Business at Western University.  Don has always found great personal reward by helping others live better lives through the innovative technology he has been fortunate to provide to Canadian healthcare practitioners throughout his career.   Don joined Khure Health as its President in early 2020 and found the potential opportunity of Khure’s technology to improve the lives of so many complex and rare disease patients with earlier diagnosis to be something he was immediately passionate about.  When he joined the company had 2 staff members and a minimal viable product just entering the market.  Don and the team were successful in growing the business exponentially and rapidly developing their innovative product offering such that multiple acquisition offers came soon after.   In April 2021 Khure was successfully acquired by MCI Onehealth Technologies (DRDR:TSX) for $13.5M.  MCI hired Don on to continue to lead and grow the company as its Global President and General Manager.   In 2021, Don was awarded Start-up Innovator of Year by Digital Health Canada for the game changing technology and support Khure Health is providing to Canadian physicians.